International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Pneumonia caused by Candida kefyr in a Pediatric patient with Acute Lymphoblastic Leukaemia: Case Report

Author Affiliations

  • 1Departments of Microbiology, King George’s Medical University (KGMU), Lucknow-226003, UP, INDIA
  • 2 Departments of Pediatrics, King George’s Medical University (KGMU), Lucknow-226003, UP, INDIA

Int. Res. J. Medical Sci., Volume 1, Issue (1), Pages 18-19, February,28 (2013)

Abstract

Acute lymphoblastic leukaemia (ALL)is one of the commonest malignancies in children. The disease per se and immunosuppressant cytotoxic drugs administered, together make the patients of ALL very prone to secondary infections. Yeasts recovered from pulmonary tissue are mostly treated as colonisers and left unreported, though they can also be rarely responsible for pneumonia, especially in settings of haematological malignancies. Here we report a case of lung infection due to Candida kefyr in a patient with ALL.

References

  1. Esparza S.D. and Sakamoto K.M., Topics in Pediatric Leukemia – Acute Lymphoblastic Leukemia, Medscape Gen. Med., 7, 23 (2005)
  2. Meckler G. and Lindemulder S., Fever and Neutropenia in patients with Cancer, Emergency Med. Clin. North Am., 27,529-44 (2009)
  3. Chong C.Y., Tan A/.M. and Lou J., Infections in Acute Lymphoblastic Leukaemia, Annals Acad. Med. Singapore, 27, 491-95 (1998)
  4. Rosenow E.C., Wilson W.R. and Cockerill F.R., Pulmonary disease in the immunocompromised host, Mayo Clin. Proc.,60, 473-487 (1985)
  5. Hildebrand F.L. Jr., Rosenow E.C., Habermann T.M. and Tazelaar H.D., Pulmonary complications of leukemia, Chest,98, 1233-1239 (1990)
  6. Vento S., Cainelli F. and Temesgen Z., Lung infections after cancer chemotherapy, Lancet Oncol., 982-92 (2008)
  7. Souza C.A., Muller N.L., Marchiori E., Escuissato D.L. and Franquet T., Pulmonary Invasive Aspergillosis and Candidiasis in Immunocompromised Patients:A Comparative Study of the High-Resolution CT findings, J. Thorac. Imaging, 21, 184–189 (2006)
  8. Larone D.H., Medically important Fungi: A guide to Identification, 5th Edition, ASM press, Washington DC (2011)
  9. NCCLS, Method for antifungal disk diffusion susceptibility testing of yeasts, Approved Standard M44-A2 (2008)
  10. Falcone M., Accarpio F., Venditti M., Vena A., Sibio S., Sammartino P., Di Giorgio A., Septic bilateral pulmonary candidiasis successfully treated with anidulafungin therapy in two patients with peritoneal carcinomatosis, J. Antimicrob. Chemother(2010)
  11. Sendid B., Lacroix C. and Bougnoux M.,Is Candida kefyr an Emerging Pathogen in Patients with Oncohematological Diseases?, Clin. Inf. Dis., 43, 666–67 (2006)
  12. Weichert S., ReinshagenK., Zahn K., Geginat G., Dietz A. , Kilian A.K., Schroten H. and Tenenbaum T., Candidiasis caused by Candida kefyr in a neonate: Case report, BMC Microbiol., 12, 61 (2012)